Localized Colorectal Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Featuring perspectives from Dr Stacey A Cohen, Dr Christopher Lieu and Dr Jenny Seligmann, moderated by Dr Lieu, including the following topics:

• Role of circulating tumor DNA (ctDNA) testing in the escalation of treatment for Stage II and deescalation for Stage III colon cancer (0:00)
• Impact of timing on the clinical relevance of ctDNA minimal residual disease test results in localized colorectal cancer (8:58)
• Approach to managing Stage III colon cancer with ctDNA-positive results after adjuvant treatment (13:35)

CME information and select publications